Want to join the conversation?
Pharmaceutical giant $PFE updates its FY15 guidance to include its acquisition of $HSP, completed on Sept. 3, 2015. $PFE now expects revenues to be $46.5-47.5Bil from $45-46Bil previous & GAAP EPS to be $1.29-1.38 from $1.38-1.47 previous. The expected impact of including $HSP's operations on revenues and GAAP EPS is $1.5Bil & ($0.09) respectively.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.